2023 Q3 Form 10-Q Financial Statement

#000164033423001510 Filed on August 10, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2023 Q1
Revenue $0.00 $0.00 $58.40K
YoY Change
Cost Of Revenue $0.00 $0.00
YoY Change
Gross Profit $0.00 $58.40K
YoY Change
Gross Profit Margin 100.0%
Selling, General & Admin $21.77K $11.34K $86.77K
YoY Change -80.68% -90.58% -26.88%
% of Gross Profit 148.58%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $21.77K $11.34K $86.77K
YoY Change -80.69% -90.58% -26.88%
Operating Profit -$21.77K -$11.34K -$28.37K
YoY Change -80.69% -90.58%
Interest Expense $0.00 $0.00 $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net -$11.00 $658.00 -$80.00
YoY Change -107.1% -21.01% -52.94%
Pretax Income -$21.78K -$10.68K -$28.45K
YoY Change -80.65% -91.07% -76.06%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$21.78K -$10.68K -$28.45K
YoY Change -80.65% -91.07% -76.06%
Net Earnings / Revenue -48.72%
Basic Earnings Per Share
Diluted Earnings Per Share $0.00 $0.00 -$0.01
COMMON SHARES
Basic Shares Outstanding 122.0M shares 1.984M shares 1.984M shares
Diluted Shares Outstanding 122.0M shares

Balance Sheet

Concept 2023 Q3 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $460.00 $730.00 $900.00
YoY Change -78.2% -52.6% 69.81%
Cash & Equivalents $457.00 $726.00 $900.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $9.985K $9.991K $10.32K
YoY Change 2.29% 14.38% 50.88%
LONG-TERM ASSETS
Property, Plant & Equipment $3.910K $4.130K $2.600K
YoY Change -85.21% -89.63% -59.88%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $3.908K $4.133K $2.600K
YoY Change -85.21% -89.62% -59.88%
TOTAL ASSETS
Total Short-Term Assets $9.985K $9.991K $10.32K
Total Long-Term Assets $3.908K $4.133K $2.600K
Total Assets $13.89K $14.12K $12.92K
YoY Change -61.61% -70.91% -3.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $252.0K $242.4K $231.7K
YoY Change 23.45% 23.21% 30.63%
Accrued Expenses $440.00 $440.00 $6.460K
YoY Change -98.36% -98.91% -75.6%
Deferred Revenue
YoY Change
Short-Term Debt $23.37K $23.44K $286.7K
YoY Change -90.37% -90.07% 25.37%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.600M $2.588M $2.621M
YoY Change 0.15% 1.25% 6.63%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $4.260K $4.280K
YoY Change
Total Long-Term Liabilities $4.260K $4.280K $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $2.600M $2.588M $2.621M
Total Long-Term Liabilities $4.260K $4.280K $0.00
Total Liabilities $2.605M $2.592M $2.621M
YoY Change 0.31% 1.42% 6.63%
SHAREHOLDERS EQUITY
Retained Earnings -$2.805M -$2.783M -$2.773M
YoY Change 6.51% 10.4% 15.45%
Common Stock $122.0K $122.0K $122.0K
YoY Change 6048.39% 6048.39% 6048.39%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$2.591M -$2.578M -$2.608M
YoY Change
Total Liabilities & Shareholders Equity $13.89K $14.12K $12.92K
YoY Change -61.61% -70.91% -3.01%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income -$21.78K -$10.68K -$28.45K
YoY Change -80.65% -91.07% -76.06%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$11.88K $4.356K $15.33K
YoY Change -71.46% -109.03% -143.35%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 4.430K $2.656K -28.27K
YoY Change -89.5% -94.61% -180.15%
NET CHANGE
Cash From Operating Activities -11.88K $4.356K 15.33K
Cash From Investing Activities 0.000 $0.00
Cash From Financing Activities 4.430K $2.656K -28.27K
Net Change In Cash -7.450K -$170.00 -12.94K
YoY Change -1362.71% -116.68% 14277.78%
FREE CASH FLOW
Cash From Operating Activities -$11.88K $4.356K $15.33K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 elre Short Term Loan Related Party
ShortTermLoanRelatedParty
253003 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
0 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
231738 usd
CY2023Q2 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
438 usd
CY2023Q2 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
4276 usd
CY2023Q2 dei Entity Central Index Key
EntityCentralIndexKey
0001438461
CY2023Q2 dei Amendment Flag
AmendmentFlag
false
CY2023Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
CY2023Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2022Q1 us-gaap Common Stock No Par Value
CommonStockNoParValue
0.001
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3000000000 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
121983993 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
121983993 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
121983993 shares
CY2023Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2023Q2 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
0 usd
CY2023Q1 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
0 usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2023Q2 us-gaap Advertising Expense
AdvertisingExpense
0 usd
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14342562 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1983993 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1983993 shares
CY2023Q2 dei Document Type
DocumentType
10-Q
CY2023Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q2 dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
CY2023Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q2 dei Entity File Number
EntityFileNumber
333-152242
CY2023Q2 dei Entity Registrant Name
EntityRegistrantName
YINFU GOLD CORPORATION
CY2023Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
WY
CY2023Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-8531222
CY2023Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
Suite 2313
CY2023Q2 dei Entity Address Address Line2
EntityAddressAddressLine2
Dongfang Science and Technology Mansion
CY2023Q2 dei Entity Address Address Line3
EntityAddressAddressLine3
Nanshan District
CY2023Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
Shenzhen
CY2023Q2 dei Entity Address Country
EntityAddressCountry
CN
CY2023Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
518000
CY2023Q2 dei City Area Code
CityAreaCode
755
CY2023Q2 dei Local Phone Number
LocalPhoneNumber
8316-0998
CY2023Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q2 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q2 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q2 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Security12b Title
Security12bTitle
Common stock, par value $0.001 per share
CY2023Q2 dei Trading Symbol
TradingSymbol
ELRE
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
121983993 shares
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
726 usd
CY2023Q2 us-gaap Other Receivables
OtherReceivables
9265 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
9991 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4133 usd
CY2023Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
4133 usd
CY2023Q2 us-gaap Assets
Assets
14124 usd
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
242398 usd
CY2023Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
23436 usd
CY2023Q1 us-gaap Short Term Borrowings
ShortTermBorrowings
24749 usd
CY2023Q1 elre Short Term Loan Related Party
ShortTermLoanRelatedParty
261932 usd
CY2023Q1 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
453 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6007 usd
CY2023Q2 elre Due To Related Party
DueToRelatedParty
2068945 usd
CY2023Q1 elre Due To Related Party
DueToRelatedParty
2095837 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 usd
CY2023Q1 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
0 usd
CY2023Q1 us-gaap Liabilities
Liabilities
2620716 usd
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
121984 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7934 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2772553 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
34843 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-2607792 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
14124 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12924 usd
CY2022Q2 us-gaap Revenues
Revenues
0 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6003 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
99336 usd
CY2023Q2 us-gaap Professional Fees
ProfessionalFees
5335 usd
CY2022Q2 us-gaap Professional Fees
ProfessionalFees
21070 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
11338 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
120406 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-11338 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-120406 usd
CY2023Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
0 usd
CY2022Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
1 usd
CY2023Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
658 usd
CY2022Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
832 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
658 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
833 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-10680 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-119573 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-10680 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-119573 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
40100 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
56250 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
29420 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-63323 usd
CY2023Q2 elre Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
-0.00
CY2022Q2 elre Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
-0.06
CY2023Q2 elre Weighted Average Number Of Share Outstanding Basic And Diluted Share
WeightedAverageNumberOfShareOutstandingBasicAndDilutedShare
121983993 shares
CY2022Q2 elre Weighted Average Number Of Share Outstanding Basic And Diluted Share
WeightedAverageNumberOfShareOutstandingBasicAndDilutedShare
1983993 shares
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-2444427 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-119573 usd
CY2022Q2 us-gaap Temporary Equity Foreign Currency Translation Adjustments
TemporaryEquityForeignCurrencyTranslationAdjustments
56250 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-2507750 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-2607792 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-10680 usd
CY2023Q2 us-gaap Temporary Equity Foreign Currency Translation Adjustments
TemporaryEquityForeignCurrencyTranslationAdjustments
40100 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-2578372 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-10680 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-119573 usd
CY2023Q2 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
2699 usd
CY2022Q2 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
14363 usd
CY2023Q2 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-351 usd
CY2022Q2 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-1232 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
18579 usd
CY2022Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
91319 usd
CY2023Q2 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-5891 usd
CY2022Q2 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-33109 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4356 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-48232 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2023Q2 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
2656 usd
CY2022Q2 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
17567 usd
CY2023Q2 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 usd
CY2022Q2 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
31705 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2656 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
49272 usd
CY2023Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-7182 usd
CY2022Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-21 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-170 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1019 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
896 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
525 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
726 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1544 usd
CY2023Q2 elre Recognized Rou Assets Through Lease Liabilities
RecognizedROUAssetsThroughLeaseLiabilities
4428 usd
CY2022Q2 elre Recognized Rou Assets Through Lease Liabilities
RecognizedROUAssetsThroughLeaseLiabilities
48532 usd
CY2023Q2 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2022Q2 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q2 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
67218 usd
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2023Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2023Q2 elre Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
-0.00
CY2022Q2 elre Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
-0.06
CY2022Q2 us-gaap Advertising Expense
AdvertisingExpense
0 usd
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1983993 shares
CY2023Q2 elre Lease Payment At Present Value
LeasePaymentAtPresentValue
4276 usd

Files In Submission

Name View Source Status
0001640334-23-001510-index-headers.html Edgar Link pending
0001640334-23-001510-index.html Edgar Link pending
0001640334-23-001510.txt Edgar Link pending
0001640334-23-001510-xbrl.zip Edgar Link pending
elre-20230630.xsd Edgar Link pending
elre_10q.htm Edgar Link pending
elre_ex311.htm Edgar Link pending
elre_ex312.htm Edgar Link pending
elre_ex321.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
elre-20230630_def.xml Edgar Link unprocessable
elre-20230630_cal.xml Edgar Link unprocessable
elre-20230630_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
elre-20230630_pre.xml Edgar Link unprocessable
elre_10q_htm.xml Edgar Link completed
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending